About
Neutrophil-Modulation Therapy
Areas of Focus
Categories
NanotechNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
113
By Phase
PHASE1: 1PHASE2: 1PHASE1/PHASE2: 1
By Status
SUSPENDED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06356259Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants
PHASE1Terminated
83 participants
Started: Jun 7, 2023 · Completed: Jan 23, 2025
NCT03755167Lead Sponsor
A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV
PHASE2Suspended
15 participants
Started: Dec 9, 2018 · Completed: Feb 28, 2027
NCT03652805Lead Sponsor
A Study of IPL344 in the Treatment of ALS Patients
PHASE1/PHASE2Suspended
15 participants
Started: Aug 1, 2018 · Completed: Feb 28, 2026
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...